<VariationArchive VariationID="2691428" VariationName="NC_000004.11:g.(?_155484162)_(155493960_?)del" VariationType="Deletion" Accession="VCV002691428" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-14" DateCreated="2024-02-04" MostRecentSubmission="2024-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2852455" VariationID="2691428">
      <GeneList>
        <Gene Symbol="FGB" FullName="fibrinogen beta chain" GeneID="2244" HGNC_ID="HGNC:3662" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>4q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="154562980" stop="154572807" display_start="154562980" display_stop="154572807" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="155484131" stop="155493914" display_start="155484131" display_stop="155493914" Strand="+" />
          </Location>
          <OMIM>134830</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000004.11:g.(?_155484162)_(155493960_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" innerStart="155484162" innerStop="155493960" display_start="155484162" display_stop="155493960" variantLength="9799" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.(?_155484162)_(155493960_?)del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.(?_155484162)_(155493960_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000004.11:g.(?_155484162)_(155493960_?)del AND Congenital afibrinogenemia" Accession="RCV003486504" Version="1">
        <ClassifiedConditionList TraitSetID="5332">
          <ClassifiedCondition DB="MedGen" ID="C2584774">Congenital afibrinogenemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-04" MostRecentSubmission="2024-02-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5332" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12543" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital afibrinogenemia</ElementValue>
                <XRef ID="MONDO:0008737" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5761" />
                <XRef ID="5761" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="335" DB="Orphanet" />
              <XRef ID="98880" DB="Orphanet" />
              <XRef ID="C2584774" DB="MedGen" />
              <XRef ID="MONDO:0008737" DB="MONDO" />
              <XRef Type="MIM" ID="202400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7917644" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="NC_000004.11:g.(?_155484162)_(155493960_?)del|MedGen:C2584774" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004241722" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: The variant involves the deletion of exons 1-8 (full coding region) in the FGB gene. A presumed nomenclature of c.(?_-9)_(*2158_?)del has been designated for the purposes of this classification. This deletion includes the entire coding sequence of the gene. As the exact proximal and distal breakpoints are unknown, it may extend beyond the annotated region of the gene to include other flanking genes. The variant was absent in 21694 control chromosomes (gnomAD Structural variants dataset). To our knowledge, no occurrence of c.(?_-9)_(*2158_?)del in individuals affected with Afibrinogenemia, Congenital and no experimental evidence demonstrating its impact on protein function have been reported. Other loss of function (pLoF) variants are reported in patients affected with Afibrinogenaemia (PMIDs: 12511408, 35488806). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FGB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.(?_155484162)_(155493960_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2584774" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14175850</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7917644" TraitType="Disease" MappingType="XRef" MappingValue="C2584774" MappingRef="MedGen">
        <MedGen CUI="C2584774" Name="Congenital afibrinogenemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

